Brief: Rubius Therapeutics Posts Q2 Loss Per Share $0.49
09/08/2022 15:06
Aug 9 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.49
* Q2 EARNINGS PER SHARE VIEW $-0.53 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXqQ4Rl
Further company coverage: RUBY.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft